Literature DB >> 16585990

Clinicopathological analysis of 1571 cutaneous malignant melanomas in Valencia, Spain: factors related to tumour thickness.

Eduardo Nagore1, Vicente Oliver, Rafael Botella-Estrada, Salvador Moreno-Picot, Carlos Guillén, José M Fortea.   

Abstract

Epidemiological studies on cutaneous melanoma in Mediterranean countries are scarce. Our aim was to perform a descriptive analysis of melanoma cases diagnosed in Valencia, Spain, and to evaluate the relationship between Breslow thickness and some clinical features. A total of 1571 patients with histologically confirmed cutaneous malignant melanoma diagnosed at the two main referral melanoma centres were evaluated retrospectively. For each patient the following clinical and pathological characteristics were selected: age, gender, anatomic site, histogenetic type, Breslow thickness, presence of ulceration, the stage, and symptoms such as bleeding, changes in size and colour, altered sensations and previous traumas. Chi-squared tests were performed together with logistic regression to evaluate the relationship of variables with tumour thickness. Tumour thickness was independently correlated with increasing age, presence of bleeding, location on hand or foot, and presence of altered sensations. Female sex and presence of a change in colour were associated with thin melanomas. Ideally, public awareness campaigns concerning the risks that exist should be aimed at subgroups such as men and people of an advanced age who generally present with thicker tumours. Emphasis should be placed on irregularities or changes in pigmentation, as these appear to be the first indicators of the development of a melanoma.

Entities:  

Mesh:

Year:  2006        PMID: 16585990     DOI: 10.2340/00015555-0004

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  6 in total

1.  Prognostic variables and surgical management of foot melanoma: review of a 25-year institutional experience.

Authors:  Omar M Rashid; Julia C Schaum; Luke G Wolfe; Nooshin K Brinster; James P Neifeld
Journal:  ISRN Dermatol       Date:  2011-07-26

2.  Epidemiological aspects of melanoma at a university hospital dermatology center over a period of 20 years.

Authors:  Flavia Vieira Brandão; Ana Francisca Junqueira Ribeiro Pereira; Bernardo Gontijo; Flávia Vasques Bittencourt
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

3.  Epidemiological and clinical characteristics of malignant melanoma in Southeast Anatolia in Turkey.

Authors:  Bilal Sula; Feyzullah Uçmak; Mehmet Ali Kaplan; Zuhat Urakçi; Mustafa Arica; Abdurrahman Isikdogan
Journal:  Pan Afr Med J       Date:  2016-05-06

4.  Which symptoms are linked to a delayed presentation among melanoma patients? A retrospective study.

Authors:  Sally Jane O'Shea; Zoe Rogers; Fiona Warburton; Amanda J Ramirez; Julia A Newton-Bishop; Lindsay J L Forbes
Journal:  BMC Cancer       Date:  2017-01-03       Impact factor: 4.430

Review 5.  PLGA-loaded nanomedicines in melanoma treatment: Future prospect for efficient drug delivery.

Authors:  Sreemanti Das; Anisur Rahman Khuda-Bukhsh
Journal:  Indian J Med Res       Date:  2016-08       Impact factor: 2.375

6.  Predictive factors of melanoma thickness.

Authors:  Ana Rita Carreiro Silva; Ricardo José David Costa Vieira
Journal:  An Bras Dermatol       Date:  2022-06-25       Impact factor: 2.113

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.